Imfinzi™ (durvalumab)

No prior authorization required for:

  • Emergency room
  • Inpatient
  • Skilled nursing facility

Injectable auth/billing notes:

Medications billed with miscellaneous codes will be reviewed. Explanatory notes must accompany the claim.

Priority Health Medicare applies CMS local coverage determination criteria when available for Part B drugs.

Code(s): J3590, C9492

Benefit: Medical

Notes: For treatment of locally advanced or metastatic urothelial carcinoma, non-small cell lung cancer